Why Juno Therapeutics Crashed 57.1% in 2016 and What's Next

Image source Getty Images What happened After reporting that it has halted trials of its most advanced cancer drug 160 shares in Juno Therapeutics NASDAQ JUNO lost 57 1 of their value in 2016 according to S amp P Global Market Intelligence So